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Background. Genetic noise between outbred animals can po-
tentially be a major confounder in the use of microarray tech-
nology for gene expression profiling. The study of paired or-
gans from the same animal offers an alternative approach (e.g.,
for studies of the kidney in experimental hypertension). The
present study was undertaken to determine the level of genetic
noise between outbred adult Sprague-Dawley (SD) rats, and to
determine the effects of unilateral nephrectomy on changes in
gene expression as a basis for the design of microarray studies
in experimental hypertension.
Methods. Male SD rats (approximately 130 g) were acclima-
tized before measurement of tail-cuff systolic blood pressure
(SBP) for 6 control days and 4 days of saline treatment. Left
kidney nephrectomy was performed, and the tissue snap-frozen
in liquid nitrogen for subsequent RNA extraction. Two weeks
later, SBP was measured over 4 control and 8 saline treatment
days, and the remaining right kidney removed and frozen. To-
tal RNA purification, preparation of cRNA, hybridization, and
scanning of the Rat U34A Affymetrix arrays were performed,
and data analyzed using MAS5 software Affymetrix Suite (v5),
Bioconductor, as well as statistical methods motivated by rele-
vant simulations.
Results. Gene expression profiles in the left control kidney
were extremely consistent across animals. The expression pro-
files of pairs of kidneys from the same animal were, however,
more similar than those of kidneys from different animals.
Nephrectomy had little effect on the gene expression profiles
in the time frame examined.
Conclusion. Despite the outbred nature of the rats used in this
study, they are useful for gene expression profiling comparisons.
The use of paired organs from an individual animal ensures
even further genetic identity, allowing determination of genes
modified by the treatment of interest.
‘For gene hunting in hypertension the kidney is an
ideal choice as several elegant transplantation experi-
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ments showed that hypertension always travels with the
kidney’ [1].
Microarray technology allows assessment of gene ex-
pression in a variety of physiologic, pathologic, and ex-
perimental conditions. However, a potential drawback of
the use of this technique is the lack of genetic identity be-
tween the outbred animals used in many of these studies.
Thus, in analyzing microarray data in physiologic exper-
iments, it may be difficult to distinguish specific changes
in gene expression from noise due to genetic variabil-
ity. Thus, there is a need to understand the level of vari-
ability in gene expression profiles for outbred rats used
in hypertension studies. One way of dealing with this
problem is to use the animal as its own control, and the
kidney, as a paired organ, is ideal in this regard. How-
ever, any experimental protocol using paired kidneys
must take into account the possible changes produced by
nephrectomy.
This study was undertaken to determine the effects of
both genetic variability and nephrectomy in the adult out-
bred Sprague-Dawley rat on changes in gene expression
in the kidney as a basis for the design of microarray stud-
ies in experimental hypertension.
METHODS
Experimental animals and design
Eight male Sprague-Dawley rats (∼130 g body weight;
Animal Resource Centre, WA, Australia) were housed
in a room with constant temperature (21–23◦C), with a
12-hour alternating light dark cycle (700-1900 hour), and
given free access to a commercial rodent diet and tap
water. Two rats were studied in each of 4 identical exper-
iments. After an acclimatization period of 1-week hold-
ing and 1-week adaptation, systolic blood pressure (SBP)
measurements (tail-cuff) and weights were recorded on
alternate days for 6 control days and 4 treatment days
[saline, daily 1 mL/kg SC or heparinized saline solution
(10 IU/mL) at 5 lL/hr via an osmotic mini-pump (Alza
Corp., Palo Alto, CA, USA)]. Left (L) nephrectomy was
performed on treatment day 4 on the 8 animals, and
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Table 1. Experimental design for control left kidneys and
nephrectomy right kidneys
Experiment Sample name Treatment
1 L1 Control rat 1
L2 Control rat 2
R2 Nephrectomy rat 2
2 L3 Control rat 3
L4 Control rat 4
R4 Nephrectomy rat 4
3 L5 Control rat 5
L6 Control rat 6
R6 Nephrectomy rat 6
4 L7 Control rat 7
L8 Control rat 8
R8 Nephrectomy rat 8
the kidney snap-frozen in liquid nitrogen for subsequent
RNA extraction. These kidney samples are referred to
as L1-L8. The rats were then allowed to recover for 2
weeks. After this recovery period, SBP and weight were
measured on alternate days for 4 days control, and then
over 8 days of saline treatment as above. At sacrifice,
the right (R) kidney was removed from rats 2, 4, 6, and
8, weighed, and snap-frozen and referred to as R2, R4,
R6, and R8 (Table 1). Kidneys were stored at −70◦C.
Rats 1–6 were housed at The Australian National Univer-
sity, and rats 7 and 8 were housed at Monash University.
The Animal Experimental Ethics Committees from the
Australian National University (JHB.01.99 & JHB.08.01)
and Monash University (PHYS 2002/09) approved these
studies.
RNA isolation, preparation of cRNA, and gene chip
hybridization
Total RNA was extracted from each of the kidneys us-
ing Tri-Reagent (T-9424; Sigma, St. Louis, MO, USA),
and further purified using the RNeasy spin column kit
(74104; Qiagen, Hilden, Germany). The integrity of the
RNA was assessed by analysis on 1.2% formaldehyde-
agarose gels. Preparation of cRNA, hybridization, and
scanning of the Test3 arrays and Rat U34A arrays
were performed according to the manufacturer’s proto-
col (Affymetrix, Santa Clara, CA, USA). Briefly, double-
stranded cDNA was synthesized from 5 to 8 lg of each
RNA sample via oligo T7-(dT)24 primer-mediated re-
verse transcription. Biotin-labeled cRNA was generated
using the Enzo BioArray kit (Affymetrix), purified us-
ing RNeasy spin columns (Qiagen), and then quanti-
fied by spectrophotometer. Fifteen to 20 lg of each
biotin-labeled fragmented cRNA sample was used to
prepare 300 lL of hybridization mixture. Aliquots of
each sample (100 lL) were hybridized onto Test3 ar-
rays to check the quality of the samples prior to hy-
bridization (200 lL) onto the Rat U34A arrays (∼7000
full-length sequences and ∼1000 EST clusters). The ar-
rays were washed with optimized wash protocols, stained
with strepdavidin/phycoerythrin followed by antibody
amplification, and scanned with the Agilent GeneAr-
ray Scanner (Affymetrix). During the course of these
experiments, the scanner setting was altered on advice
from Affymetrix to prevent saturation. Experiment 1 was,
therefore, scanned on the old scanner setting, while all
other experiments were scanned on the new settings.
Data analysis
Quality control (QC) was carried out using both MAS5
criteria (background, scale factor, control gene hybridiza-
tion) and appropriate statistical plots of the log2 CEL file
intensities, including box plots for each array and density
plots for all arrays plotted separately and together (be-
cause these different displays allow comparisons of dif-
ferent features of the distributions between arrays), his-
tograms of PM (perfect match) transformed intensities
(to detect saturation) and histograms, scatter plots and
Q–Q plots (to compare each pair of arrays). Box plots of
the Affymetrix CEL files were generated using the box
plot function in the base package in R (Bioconductor
version 1.8.0) with all input parameters set to default
values. Affymetrix CEL files were imported into R us-
ing the ReadAffy function in the affy package available
from Bioconductor (www.bioconductor.org) [2]. Differ-
ent analysis methods use different normalization proce-
dures and scale factors, and these can have large effects on
subsequent analyses. Thus, we have used a number of dif-
ferent methods to analyze these data. Data were first an-
alyzed using the MAS5 software (Affymetrix Suite v5.0),
where pairs of samples (either control pairs from differ-
ent animals or pairs of kidneys from the same animal)
were compared using both absent/present calls and sig-
nal values. Hierachic clustering of arrays, with appropri-
ate gene filtering, was carried out on the log2 Affymetrix
signals from each array using the hclust function from
the mva package in R (Bioconductor version 1.8.0) [2].
The Euclidean distance metric and average agglomera-
tion methods were used. A third analysis method was
used which was based on synthetic data simulation in ac-
cord with current biological and technical understanding
of microarray data [3]. Gene expression values were con-
verted to log2 values, both the samples and genes centered
(mean 0), the samples standardized (variance 1) [3]. Then,
gene filtering was carried out for further analysis. A use-
ful ordination method, the GE-biplot, is obtained from
the Singular Value Decompositor of the resultant matrix.
On this plot, the genes and chips are both represented
[3].
RESULTS
There was no significant change in blood pressure in re-
sponse to nephrectomy (112 ± 2 before and 119 ± 2 mm
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Fig. 1. Box plots of the log2 Affymetrix signal values for all the samples
L1-L8 and R2, 4, 6, and 8 as output by Bioconductor.
Hg, after unilateral nephrectomy, P = 0.2). Renal hyper-
trophy was evident in the right kidney following nephrec-
tomy, both in absolute terms (L 1.32 ± 0.08, R 2.09 ±
0.10 g, P = 0.001) and relative to body weight (4.24 ±
0.19 to 5.41 ± 0.31 mg/g, respectively; P = 0.01).
MAS5 analysis of the 8 control and 4 nephrectomy
chips showed that one of the control samples, L2, had
a higher background than the other samples in the same
experiment. Further QC analysis of the entire data set
also demonstrated this, and clearly identified those chips
(L1, L2 and R2) that were scanned on the old scanner
settings (Fig. 1). Some laser saturation effects were also
evident (plots not shown). Because of these problems, ex-
periment 1 was not included in any further data analysis.
Hierarchic clustering in R using hclust and log2 of the
Affymetrix signal values [filtered for genes present on at
least 3 of the chips (4242genes)] with the remaining 6 left
kidneys showed that pairs of samples prepared and ana-
lyzed in the same “batch” were more similar to each other
(Fig. 2A) than to any other left kidney. This experimental
clustering was also evident in a GE-biplot representation
of the L3-L8 samples (Fig. 2B). The advantage of the
GE-biplot is that samples and genes can be represented
simultaneously on the one plot, and interpreted with re-
spect to each other. The most salient features of this plot
are: (1) samples that have approximately the same rela-
tive indices for all the genes will cluster together; (2) the
Euclidean distance from a gene point to the origin is an
approximation to the standard deviation of the gene’s ex-
pression index; and (3) genes that lie in the direction of,
for these data, any pair of samples (e.g., L3/L4) are rela-
tively up-regulated in this pair compared with the other
2 pairs, while those lying in the opposite direction are
relatively down-regulated. One can observe differential
30 32 34 36 38
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Fig. 2. Clustering of control samples L3–L8. Hierarchic clustering was
carried out using hclust in R on the log2 Affymetrix signal values
using the unweighted pair group method with arithmetic mean and
Euclidean distance as the similarity measure. (A). Genes were selected
based on their presence on at least 3 of the chips using the Affymetrix
present/absent calls. GE-biplot of control samples L3–L8 using 4242
genes selected on the basis of their presence on at least 3 of the chips
(B). The position of each chip is shown as a label joined by a dotted line
to the origin, and each gene is shown as ∼.
expression between the 3 pairs of samples for many of the
genes, and it was necessary to evaluate whether these dif-
ferences are statistically significant. This evaluation was
done using analysis of variance (ANOVA) with the null
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Fig. 3. Clustering of 3 pairs samples of nephrectomy samples (L4:R4;
L6:R6; L8:R8). Hierarchic clustering using hclust in R was carried out
on the log2 Affymetrix signal values using the unweighted pair group
method with arithmetic mean and Euclidean distance as the similarity
measure (A). Genes were selected based on their presence on at least
one of the chips using the Affymetrix present/absent calls. GE-biplot
of 3 pairs of nephrectomy samples (L4:R4; L6:R6; L8:R8) using 4885
genes selected on the basis of their presence on at least 1 of the chips
(B). The position of each chip is shown as a label joined by a dotted line
to the origin, and each gene is shown as ∼.
hypothesis of no difference in mean gene expression be-
tween the 3 pairs for the selected (4242) genes. We used
P values of 0.01 and 0.001, and found that 122 (data
not shown) and 15 genes (Table 2), respectively, showed
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evidence of significant differences at these levels. These
data show that there are relatively few differences be-
tween the gene expression profiles in the control kidneys
of these outbred rats.
To determine what effect unilateral nephrectomy had
on the gene expression pattern in the remaining kidney,
expression profiles were generated from pairs of kid-
neys before and after nephrectomy (i.e., L4:R4, L6:R6,
L8:R8), and again, hierarchic clustering and the GE-
biplot were used to evaluate similarities and differences.
Using both approaches, the expression profiles of kid-
ney pairs from the same animal were more similar than
those from different animals (Fig. 3A and B). Because
the samples cluster according to animals, and not before
and after nephrectomy, it appears that nephrectomy does
not lead to major global changes in gene expression, at
least when measured 3 to 4 weeks following the operation.
To evaluate whether there are statistically significant dif-
ferences between left (control) and right (nephrectomy)
kidneys from the paired animals, paired t tests were per-
formed. Only 37 genes showed evidence of significant
differences (P < 0.01) between kidney pairs (Table 3).
For these evaluations, the data were normalized to mean
0, variance 1 within the samples, and the values for those
genes showing differential expression levels between left
and right kidneys were found to have relatively small
differences.
DISCUSSION
A possible problem in interpretation of microarray
data is genetic variability between outbred animals in
physiologic experiments. To our knowledge, microarray
studies have not been carried out on outbred rats, but it
has been predicted from computation studies of microar-
ray analysis on human tissues that variation due to lack of
genetic identity should be a major issue, at least in human
populations [4]. The use of outbred SD rats is common
in studies of hypertension. Thus, it is important to de-
termine if the genetic variability between these animals
leads to substantial changes in gene expression profiles.
Our detailed comparison here of 6 of these animals leads
us to conclude that there is only a low level of variation
in gene expression between the kidneys of these animals.
This is despite the fact that 2 of the animals were housed
separately, and the experiments were performed in pairs
over a period of 24 months. The only clustering effect ob-
served was a “batch” effect (i.e., samples prepared at the
same time were more similar to each other than samples
prepared at different times). Thus, it should be possible
to combine gene expression data from a number of repli-
cate rats to generate meaningful results when examining
the effect of specific treatments.
Unilateral nephrectomy is known to lead to significant
changes in both structure and function in the remaining
370 Shannon et al: Optimizing microarray in experimental hypertension
kidney [5, 6]. In the present study, we observed the
expected increase in weight in the remaining kidney af-
ter the removal of the contralateral kidney. Nephrec-
tomy is not uncommon clinically in adults; in living donor
transplantation, following trauma, and in various disease
states (e.g., malignancy). In general, the clinical seque-
lae, if any, are mild. Nephrectomy is also used experi-
mentally in a range of circumstances (e.g., DOCA-salt
hypertension [7] or studies of direct renal infusion of
drugs or hormones [8]). Changes appear to depend on
age at nephrectomy and are greater in younger animals
[9] and humans [10]. Sex differences have also been re-
ported [11]. In the rat models of particular interest to us,
ACTH hypertension and angiotensin II mediated vascu-
lar changes, nephrectomy does not modify the timing or
extent of the blood pressure change [8, 12]. In this study,
we used young male SD rats (body weight at nephrectomy
approximately 310 g) and found that there are a group of
genes whose expression does change upon nephrectomy,
but the degree of change is generally very low. These
genes included a group involved in fatty acid metabolism,
transport, mitochondrial function, and signal transduc-
tion. These genes are possible candidates involved in the
genesis of compensatory renal hypertrophy. A literature
search suggests genes which might be involved include
those for VEGF [13], IGF-I and II [13, 14], GH [12, 14],
TGF b [15], amylin [16], protooncogenes c-myc and c-
fos [17], cell-cycle dependent hypertrophy (G1 cell cy-
cle kinases) [18], angiotensin II, AVP, and endothelin I
[19]. These genes were all represented in the data set, but
none appeared to be altered in our studies. Accordingly,
these experiments show that it is possible to use outbred
SD rats for studies of gene expression in the kidney, and
that the use of paired organs from individual animals as
control and test ensures even closer genetic identity and
provides ideal conditions for the use of microarrays to
determine which genes are modified by the treatment of
interest.
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